OPEN END TURBO LONG - VIRBAC Stock

Certificat

DE000MG2HV27

Market Closed - Börse Stuttgart 10:50:49 2024-05-17 EDT
10.51 EUR -4.80% Intraday chart for OPEN END TURBO LONG - VIRBAC
Current month+6.70%
1 month-11.68%
Date Price Change
24-05-17 10.51 -4.80%
24-05-16 11.04 -3.33%
24-05-15 11.42 +2.61%
24-05-14 11.13 +4.70%
24-05-13 10.63 +0.95%

Delayed Quote Börse Stuttgart

Last update May 17, 2024 at 10:50 am

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying VIRBAC
Issuer Morgan Stanley
WKN MG2HV2
ISINDE000MG2HV27
Date issued 2024-04-17
Strike 251.6
Maturity Unlimited
Parity 10 : 1
Emission price 10.8
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 12.6
Lowest since issue 9.55

Company Profile

Virbac specializes in the research, production and marketing of veterinary medicines. The activity is organized around 2 product families: - pet medications: pest control drugs, vaccines, antibiotics, anesthetics, anti-inflammatory drugs, mouth/dental care products, ophthalmologic and dermatological products intended for dogs, cats, horses, birds, rodents, etc. The group also offers foods and electronic identification chips; - livestock medications: pest control drugs and antibiotics intended for cattle, sheep, pigs, poultry, etc. Net sales are distributed geographically as follows: France (15.4%), Europe (26.2%), Latin America (17.1%), Asia (16.4%), North America (13.2%), Pacific (9.3%), Africa and Middle East (2.4%).
Sector
-
More about the company

Ratings for Virbac

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Virbac

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
354.5 EUR
Average target price
372.4 EUR
Spread / Average Target
+5.06%
Consensus
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW